ciprofloxacin has been researched along with Retinal Detachment in 7 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Retinal Detachment: Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ocular bioavailability of ciprofloxacin in SRF after oral and combined administration is equivalent." | 2.69 | Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans. ( Başci, NE; Batman, C; Bozkurt, A; Cekiç, O; Yaşar, U; Zilelioğlu, O, 2000) |
| "Population-based data are needed to inform the safe prescribing of fluoroquinolone antibiotics to patients with advanced chronic kidney disease (CKD)." | 1.72 | Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease. ( Ahmadi, F; Garg, AX; Kim, RB; Knoll, GA; Muanda, FT; Silverman, MS; Sontrop, JM; Sood, MM; Weir, MA; Yoo, E, 2022) |
| " The ocular bioavailability of ciprofloxacin after local administration is equivalent for both pharmaceutical products." | 1.31 | Comparison of subretinal fluid levels of two 0.3% ciprofloxacin-containing eye drops. ( Başci, NE; Batman, C; Bozkurt, A; Cekiç, O; Kayaalp, SO; Totan, Y; Yaşar, U; Zilelioglu, O, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Taher, MK | 1 |
| Crispo, JAG | 1 |
| Fortin, Y | 1 |
| Moog, R | 1 |
| McNair, D | 1 |
| Bjerre, LM | 1 |
| Momoli, F | 1 |
| Mattison, D | 1 |
| Krewski, D | 1 |
| Muanda, FT | 1 |
| Sood, MM | 1 |
| Weir, MA | 1 |
| Sontrop, JM | 1 |
| Ahmadi, F | 1 |
| Yoo, E | 1 |
| Kim, RB | 1 |
| Silverman, MS | 1 |
| Knoll, GA | 1 |
| Garg, AX | 1 |
| Mansour, AM | 1 |
| Mansour, HA | 1 |
| Fromberg, I | 1 |
| Krause, M | 1 |
| Brückner, K | 1 |
| Lang, M | 1 |
| Seitz, B | 1 |
| Chaudhry, NA | 1 |
| Tabandeh, H | 1 |
| Rosenfeld, PJ | 1 |
| Miller, D | 1 |
| Davis, J | 1 |
| Cekiç, O | 2 |
| Batman, C | 2 |
| Yaşar, U | 2 |
| Başci, NE | 2 |
| Zilelioğlu, O | 2 |
| Bozkurt, A | 2 |
| Totan, Y | 1 |
| Kayaalp, SO | 1 |
1 trial available for ciprofloxacin and Retinal Detachment
| Article | Year |
|---|---|
Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans.
Topics: Adult; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Drug Combinations; Female; Humans; Male; | 2000 |
6 other studies available for ciprofloxacin and Retinal Detachment
| Article | Year |
|---|---|
Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Electronic Health Records; Female; | 2022 |
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Death, Sudden, Cardia | 2022 |
Reversible postoperative visual loss from ciprofloxacin corneal deposit.
Topics: Anti-Bacterial Agents; Blindness; Ciprofloxacin; Corneal Diseases; Humans; Ophthalmic Solutions; Pos | 2019 |
[Choroidal effusion after uncomplicated cataract surgery].
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cataract Extraction; | 2008 |
Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Eye | 1998 |
Comparison of subretinal fluid levels of two 0.3% ciprofloxacin-containing eye drops.
Topics: Absorption; Administration, Topical; Aged; Anti-Infective Agents; Biological Availability; Body Flui | 2001 |